Shape Memory Medical
San Jose, US · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
DM
Duncan MaitlandFounder
MH
Michael HensonExecutive
EF
Edward F. Ruppel, JrExecutive
CM
Carolyn M. BrugueraExecutive
JY
James Y LancasterExecutive
Board
TR
Thom RascheBoard director
TT
Thomas ThalerBoard director
CK
Carla Kikken-JussenBoard director
JH
Jonathan HartmanBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$81.3M disclosed across 8 rounds · 2014–2026
▶$6.9MraisedJul 2026 · 16 investors · Other Health CareRule 506(b)
▶$6.9MraisedJul 2026 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. Ruppel, JrExecutive Officer, Director
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Duncan MaitlandDirector
- Thom RascheDirector
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6.9M
- Minimum investment
- $25K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedMay 2026 · 44 investors · Other Health CareRule 506(b)
▶$17MraisedMay 2026 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thom RascheDirector
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Edward F. Ruppel, JrExecutive Officer, Director
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.5MraisedFeb 2024 · 73 investors · Other Health CareRule 506(b)
▶$30.5MraisedFeb 2024 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $37.8M
- Amount sold
- $30.5M
- Minimum investment
- $24.7K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedApr 2023 · 37 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Thomas ThalerDirector
- Duncan MaitlandDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $4.8M
- Minimum investment
- $2.8K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5MraisedJul 2022 · 37 investors · Other Health CareRule 506(b)
▶$11.5MraisedJul 2022 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ThalerDirector
- Edward RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Michael HensonDirector
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- Minimum investment
- $15.8K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedAug 2017 · 15 investors · Other Health CareRule 506(b)
▶$7MraisedAug 2017 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carolyn M. BrugueraExecutive Officer
- Thomas ThalerDirector
- Michael HensonDirector
- Jim GamettDirector
- Edward F. Ruppel, Jr.Executive Officer, Director
- Duncan MaitlandDirector
- Offering amount
- $14M
- Amount sold
- $7M
- Minimum investment
- $7.5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3MraisedApr 2016 · 12 investors · Other Health CareRule 506(b)
▶$3MraisedApr 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James Y. LancasterExecutive Officer
- Duncan MaitlandExecutive Officer, Director
- Edward F. RuppelExecutive Officer, Director
- Michael HensonDirector
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $28K
- First sale
- Apr 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$616.5KraisedJan 2015 · 10 investors · Other Health CareRule 506(b)
▶$616.5KraisedJan 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Duncan MaitlandExecutive Officer, Director
- James Y LancasterExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $616.5K
- First sale
- Dec 2014
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapMassdevice8 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Sparta Biomedical5 shared keywordsSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.
Verse Medical5 shared keywordsVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
Companies competing with Shape Memory Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $199.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Shape Memory Medical?
- Shape Memory Medical was founded by Duncan Maitland.
- Who are Shape Memory Medical's investors?
- Shape Memory Medical's investors include Emergent Medical Partners, LLP, Earlybird Venture Capital.
- How much funding has Shape Memory Medical raised?
- Shape Memory Medical has disclosed $81.3M raised across 8 rounds.
- Where is Shape Memory Medical headquartered?
- Shape Memory Medical is headquartered in San Jose, US.
